K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 310.05 INR 1.29% Market Closed
Market Cap: 5B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Operating Income
â‚ą162.2m
CAGR 3-Years
46%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą65B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą56.2B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą112.5B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą27.8B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
â‚ą21.5B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
285 INR
Overvaluation 8%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Operating Income?
Operating Income
162.2m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Operating Income amounts to 162.2m INR.

What is Kilitch Drugs (India) Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
73%

Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Kilitch Drugs (India) Ltd have been 46% over the past three years , 73% over the past five years .

Back to Top